A phase IB clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00VP, administered at 2 different dosing schedules, in HIV-1-uninfected adult participants
Latest Information Update: 16 Oct 2021
At a glance
- Drugs VRC-HIVDNA009-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 05 Oct 2007 Status changed from in progress to completed.
- 08 Nov 2005 New trial record.